Sativex® and clinical–neurophysiological measures of spasticity in progressive multiple sclerosis

Asymmetries in vestibular evoked myogenic potentials in chronic stroke survivors with spastic hypertonia: Evidence for a vestibulospinal role

(2014) Derek M. Miller et al.   CLINICAL NEUROPHYSIOLOGY

Revisiting Physiologic and Psychologic Triggers that Increase Spasticity

(2013) Chetan P. Phadke et al.   AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION

Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial

(2012) J. Corey-Bloom et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Tonic and Transient Endocannabinoid Regulation of AMPAergic Miniature Postsynaptic Currents and Homeostatic Plasticity in Embryonic Motor Networks

(2012) C. Gonzalez-Islas et al.   JOURNAL OF NEUROSCIENCE

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis

(2011) Silvia Rossi et al.   BRAIN BEHAVIOR AND IMMUNITY

Pregabalin Beneficial Effects on Sleep Quality or Health-Related Quality of Life Are Poorly Correlated With Reduction on Pain Intensity After an 8-Week Treatment Course

(2011) Santiago Perez-Lloret et al.   CLINICAL NEUROPHARMACOLOGY

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis

(2011) A. Novotna et al.   EUROPEAN JOURNAL OF NEUROLOGY

Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis

(2010) Derick T Wade et al.   Multiple Sclerosis Journal

A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis

(2010) C. Collin et al.   NEUROLOGICAL RESEARCH

Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis

(2009) Diego Centonze et al.   NEUROLOGICAL SCIENCES

Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside

(2009) Elizabeth J. Rahn et al.   Neurotherapeutics

Validity, reliability, and clinical importance of change in a 0—10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial

(2008) John T. Farrar et al.   CLINICAL THERAPEUTICS

Cannabinoid-induced effects on the nociceptive system: A neurophysiological study in patients with secondary progressive multiple sclerosis

(2008) Antonella Conte et al.   EUROPEAN JOURNAL OF PAIN

Cannabinoid Receptors: Where They are and What They do

(2008) K. Mackie   JOURNAL OF NEUROENDOCRINOLOGY

Historical and Clinical Perspectives of the Expanded Disability Status Scale

(2008) John F. Kurtzke   NEUROEPIDEMIOLOGY